Ipca Laboratories (IPCLAB) - Domestic Business Stable but Exports Volatile…
Ipca is a fully integrated pharma company manufacturing over 350 formulations and 80 APIs with exports contributing 50% of revenues in FY21.
363 Views
Ipca Laboratories - On Course to Revive Earnings Growth
The domestic formulation (DF) segment continues on its robust growth path, led by market share gain, favorable price hikes, addition of medical...
342 Views
IPCA Laboratories: Domestic Outperformance Offset by Drag in Exports
Ipca is a fully integrated pharma company manufacturing over 350 formulations and 80 APIs with exports contributing 50% of revenues in FY21
141 Views
Ipca Laboratories: Two for One Share Stock Split
The Ipca Laboratories stock has been sub-divided from one existing equity share of Rs 2 each face value into two equity shares of Rs 1 each face...
213 Views
IPCA Laboratories: Strong Performance Despite GPM Pressure
Maintain BUY due to good traction in domestic formulations and sustainable growth amid some margin pressure in medium term Target Price and...
175 Views